Compare Danaher Corporation (DHR) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Progressive Corp — how do they compare? Danaher Corporation trades at $200.9 (market cap $140.88B), while Progressive Corp trades at $211.45 (market cap $131.91B). The key difference: Danaher Corporation and Progressive Corp are close in size by market cap, and Progressive Corp pays the higher dividend (6.13%). Which is the better fit depends on your goals.
| DHR | PGR | |
|---|---|---|
Market Cap | $140.88B | $131.91B |
Sector | Health | Financials |
52-Week High | $242.05 | $252.68 |
52-Week Low | $161.91 | $190.40 |
Enterprise Value | $153.66B | $140.14B |
Dividend Yield | 0.8% | 6.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Progressive (PGR) trades at $234.48, up 1.63% today, near its consensus price target of $240.89. The stock shows strong fundamentals with revenue growth from $49.6B in 2022 to $87.6B in 2025 and a net income margin of 12.93%. Technical indicators are bullish, with the price above key moving averages. Recent news highlights focus on Q2 2026 earnings expectations due July 15, 2026.
Outlook is positive given earnings growth and analyst buy ratings, but risks include potential earnings misses and competitive pressures. The stock offers value with a P/E of 11.93, below industry averages, supporting a bullish view for long-term investors despite near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
